Class Action Lawsuit Filed Over Presence of Toxic Chemicals in Chantix
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
A class action lawsuit filed after a recent Chantix recall claims the drug was illegally marketed due to the lack of warnings that it may contain cancer-causing substances.
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.
Pfizer has issued a full recall of all Chantix nationwide, due to the presence of potentially cancer-causing chemicals.
A recent Chantix recall has resulted in a class action lawsuit against Pfizer, which claims the company sold a defective drug to consumers which put them at an increased risk…
Pfizer is recalling four additional lots of Chantix due to high levels of a potentially cancer-causing contaminant.
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.
Pfizer has halted distribution of Chantix due to the potential presence of high levels of NDMA or other nitrosamines which could increase the risk of cancer.
Participants at a recent FDA hearing said there is little data on whether smoking cessation drugs like Chantix and Zyban would be useful in treating teen electronic cigarette addictions.